Isabella Ochola-Oyier

Genomic surveillance of SARS-CoV-2 in Kenya: March 2020-October 2021..Githinji, G. Lambisia, W. A. Mohamed, K. S. Morobe, M. J. de Laurent, Z. R. Mburu, W. M. Ongera, M. E. Omuoyo, O. D. Ndwiga, L. Otieno, E. Murunga, N. Musyoki, J. KWTRP COVID Testing Team. Kilifi Rapid Response Team. Kiiru, J. Kasera, K. Amoth, P. Mwangangi, M. Aman, R. Kinyanjui, S. Warimwe, G. M. Agweyu, A. Barasa, E. Tsofa, B. Mwangangi, J. Matoke, D. Nokes, D. J. Bejon, P. Ochola-Oyier, L. I. Agoti, C. N.
1st International Conference on Public Health in Africa (CPHIA-2021), (2021). :

High anti-SARS-CoV-2 IgG antibody seroprevalence among long-distance trucking crews in Kenya within one year of the COVID-19 pandemic..Kagucia, E. W. Gitonga, J. N. Kalu, C. Kuya, N. Ochieng, B. Karia, B. Ochomo, E. Karani, A. Nyagwange, J. Mugo, D. Karanja, H. K. Tuju, J. Mutiso, A. Maroko, H. Okubi, L. Maitha, E. Mukabi, D. The TDA SARS-CoV-2 Serosurveillance Team. Aman, R. Mwangangi, M. Amoth, P. Kasera, K. NgÔÇÖangÔÇÖa, W. Nyaguara, A. Voller, S. Otiende, M. Bottomley, C. Agoti, C. N. Ochola-Oyier, L. I. Adetifa, I . M. O. Etyang, A. O. Gallagher, K. E. Uyoga, S. Barasa, E. Bejon, P. Tsofa, B. Agweyu, A. Warimwe, G. M. Scott, J. A. G.
1st International Conference on Public Health in Africa (CPHIA), (2021). :

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations..Nyagwange, J. Kutima, B. Mwai, K. Karanja, H. K. Gitonga, J. N. Mugo, D. Uyoga, S. Tuju, J. Ochola-Oyier, L. I. Ndungu, F. Bejon, P. Agweyu, A. Adetifa, I. M. O. Scott, J. A. G. Warimwe, G. M.
1st International Conference on Public Health in Africa (CPHIA), (2021). :

Prevalence of anti-SARS-CoV-2 IgG antibodies among Kenyan blood donors between June and August 2021..Uyoga, S. Otiende, M. Adetifa, I. M. O. Karanja, H. K. Gitonga, J. Mugo, D. Makale, J. Tawa, B. Singilai, A. Nyagwange, J. Tuju, J. Aman, R. Mwangangi, M. Amoth, P. Kasera, K. NgÔÇÖangÔÇÖa, W. Kilonzo, N. Chege, E. Yegon, C. Rotich, T. Orgut, I. Kagucia, E. W. Gallagher, K. E. Etyang, A. Voller, S. Bottomley, C. Lambe, T. Wright, D. Tsofa, B. Mwangangi, J. Barasa, E. Bejon, P. Ochola-Oyier, L. I. Warimwe, G. M. Scott, J. A. G. Agweyu, A.
1st International Conference on Public Health in Africa (CPHIA), (2021). :

An optimization of four SARS-CoV-2 qRT-PCR assays in a Kenyan laboratory to support the national COVID-19 rapid response teams.Mohammed, K. S. de Laurent, Z. R. Omuoyo, D. O. Lewa, C. Gicheru, E. Cheruiyot, R. Bartilol, B. Mutua, S. Musyoki, J. Gumba, H. Mwacharo, J. Riako, D. Mwangi, S. J. Gichuki, B. M. Nyamako, L. Karani, A. Karanja, H. Mugo, D. Gitonga, J. N. Njuguna, S. Gumbi, W. Tawa, B. Tendwa, M. Cheruiyot, W. Sein, Y. Nyambu, J. K. Patta, S. O. Thani, T. S. Maitha, E. K. Kitole, B. Mwakinangu, M. S. Muslih, B. S. Otieno, J. O. Nyiro, J. U. Kiyuka, P. Ndwiga, L. Wamae, K. Kimani, D. Makale, J. Morobe, J. M. Osoti, V. Lambisia, A. W. Odundo, C. Mwarumba, S. Mutunga, M. Bejon, P. Tsofa, B. Agoti, C. N. Ochola-Oyier, L. I.
Wellcome Open Res, (2020). 5:162

Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast.Agoti, C. N. Mutunga, M. Lambisia, A. W. Kimani, D. Cheruiyot, R. Kiyuka, P. Lewa, C. Gicheru, E. Tendwa, M. Said Mohammed, K. Osoti, V. Makale, J. Tawa, B. Odundo, C. Cheruiyot, W. Nyamu, W. Gumbi, W. Mwacharo, J. Nyamako, L. Otieno, E. Amadi, D. Thoya, J. Karani, A. Mugo, D. Musyoki, J. Gumba, H. Mwarumba, S. M. Gichuki B Njuguna, S. Riako, D. Mutua, S. Gitonga, J. N. Sein, Y. Bartilol, B. Mwangi, S. J. O. Omuoyo D M. Morobe J de Laurent, Z. R. Bejon, P. Ochola-Oyier, L. I. Tsofa, B.
Wellcome Open Res, (2020). 5:186

Peripheral blood mononuclear cell transcriptomes reveal an over-representation of down-regulated genes associated with immunity in HIV-exposed uninfected infants.Musimbi, Z. D. Rono, M. K. Otieno, J. R. Kibinge, N. Ochola-Oyier, L. I. de Villiers, E. P. Nduati, E. W.
Sci Rep, (2019). 9:18124

Understanding P. falciparum Asymptomatic Infections: A Proposition for a Transcriptomic Approach.Kimenyi, K. M. Wamae, K. Ochola-Oyier, L. I.
Front Immunol, (2019). 10:2398

No evidence of P. falciparum K13 artemisinin conferring mutations over a 24-year analysis in Coastal Kenya, but a near complete reversion to chloroquine wild type parasites.Wamae, K. Okanda, D. Ndwiga, L. Osoti, V. Kimenyi, K. M. Abdi, A. I. Bejon, P. Sutherland, C. Ochola-Oyier, L. I.
Antimicrob Agents Chemother, (2019). 63:

Targeted Next Generation Sequencing for malaria research in Africa: current status and outlook.Ghansah, A. Kamau, E. Amambua-Ngwa, A. Ishengoma, D. S. Maiga-Ascofare, O. Amenga-Etego, L. Deme, A. Yavo, W. Randrianarivelojosia, M. Plasmodium Diversity Network, Africa Ochola-Oyier, L. I. Helegbe, G. K. Bailey, J. Alifrangis, M. Djimde, A.
Malar J, (2019). 18:324

Few Plasmodium falciparum merozoite ligand and erythrocyte receptor pairs show evidence of balancing selection.Ochola-Oyier, L. I. Wamae, K. Omedo, I. Ogola, C. Matharu, A. Musabyimana, J. P. Njogu, F. K. Marsh, K.
Infect Genet Evol, (2019). 69:235-245

Transmission and Age Impact the Risk of Developing Febrile Malaria in Children with Asymptomatic Plasmodium falciparum Parasitemia.Wamae, K. Wambua, J. Nyangweso, G. Mwambingu, G. Osier, F. Ndung'u, F. Bejon, P. Ochola-Oyier, L. I.
J Infect Dis, (2019). 219:936-944

Polymorphisms in the K13 Gene in Plasmodium falciparum from Different Malaria Transmission Areas of Kenya.de Laurent, Z. R. Chebon, L. J. Ingasia, L. A. Akala, H. M. Andagalu, B. Ochola-Oyier, L. I. Kamau, E.
Am J Trop Med Hyg, (2018). 98:1360-1366

Geographic-genetic analysis of Plasmodium falciparum parasite populations from surveys of primary school children in Western Kenya.Omedo, I. Mogeni, P. Rockett, K. Kamau, A. Hubbart, C. Jeffreys, A. Ochola-Oyier, L. I. de Villiers, E. P. Gitonga, C. W. Noor, A. M. Snow, R. W. Kwiatkowski, D. Bejon, P.
Wellcome Open Res, (2017). 2:29

Implications from predicted B-cell and T-cell epitopes of Plasmodium falciparum merozoite proteins EBA175-RII and Rh5.Wamae, K. K. Ochola-Oyier, L. I.
Bioinformation, (2016). 12:82-91

Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population.Ochola-Oyier, L. I. Okombo, J. Wagatua, N. Ochieng, J. Tetteh, K. K. Fegan, G. Bejon, P. Marsh, K.
Malar J, (2016). 15:261

The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.Ochola-Oyier, L. I. Okombo, J. Mwai, L. Kiara, S. M. Pole, L. Tetteh, K. K. Nzila, A. Marsh, K.
Antimicrob Agents Chemother, (2015). 59:1770-5

Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya.Okombo, J. Kamau, A. W. Marsh, K. Sutherland, C. J. Ochola-Oyier, L. I.
Int J Parasitol Drugs Drug Resist, (2014). 4:152-63

Piperaquine and Lumefantrine resistance in Plasmodium berghei ANKA associated with increased expression of Ca2+/H+ antiporter and glutathione associated enzymes.Kiboi, D. Irungu, B. Orwa, J. Kamau, L. Ochola-Oyier, L. I. Nganga, J. Nzila, A.
Exp Parasitol, (2014). 147:23-32

Repeat polymorphisms in the low-complexity regions of Plasmodium falciparum ABC transporters and associations with in vitro antimalarial responses.Okombo, J. Abdi, A. I. Kiara, S. M. Mwai, L. Pole, L. Sutherland, C. J. Nzila, A. Ochola-Oyier, L. I.
Antimicrob Agents Chemother, (2013). 57:6196-204